RecruitingNCT05033990

SPIROMICS Study of Early COPD Progression (SOURCE)


Sponsor

University of Massachusetts, Worcester

Enrollment

1,000 participants

Start Date

Sep 8, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals. The study has three main goals: * To use CT scan imaging to identify which smokers will develop COPD. * To identify biomarkers predictive of smokers that will develop COPD. * To determine if sputum (phlegm) can be analyzed to predict which smokers will develop COPD. Procedures (methods): All participants will undergo study related questionnaires assessing medical history, smoke exposure and use, medication use, social and behavioral health, pulmonary symptoms, food frequency, and will provide nasal swab, blood, stool, and urine samples, pulmonary function testing to determine function, sputum induction to provide a sputum sample for airway biospecimen analysis, and CT imaging of the lungs.


Eligibility

Min Age: 30 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This large study (SOURCE) follows current or former smokers in the early stages of COPD (chronic obstructive pulmonary disease) — a lung condition that makes breathing difficult — as well as healthy non-smokers. The goal is to understand what factors cause COPD to progress quickly versus slowly, which could help develop earlier interventions. **You may be eligible if...** - You are 30–55 years old - You are a smoker or former smoker with at least 10 pack-years of smoking history (or a healthy non-smoker for the control group) - You have normal or mildly reduced lung function (early or pre-COPD), OR you are a healthy non-smoker with normal lungs **You may NOT be eligible if...** - You have severe asthma - You have very advanced COPD (severe airflow limitation) - You have significant other lung diseases unrelated to smoking - You are unwilling or unable to complete the required visits and tests Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(14)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Mayo Clinic Arizona

Scottsdale, Arizona, United States

University of California Los Angeles

Los Angeles, California, United States

University of California, San Francisco

San Francisco, California, United States

National Jewish Health

Denver, Colorado, United States

University of Illinois Chicago

Chicago, Illinois, United States

University of Iowa

Iowa City, Iowa, United States

Johns Hopkins Bayview Medical Center

Baltimore, Maryland, United States

University of Michigan

Ann Arbor, Michigan, United States

Columbia University

New York, New York, United States

Weill Cornell Medical Center

New York, New York, United States

Wake Forest

Winston-Salem, North Carolina, United States

Temple University

Philadelphia, Pennsylvania, United States

University of Utah

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05033990